Suzanne Cole

机构：Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center · ORCID：0000-0001-8390-6315

发表论文 113 篇 · 总被引 1643 次 · h-index 22

代表论文

• A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2). (2025 · Journal of Clinical Oncology · 被引 29)
• Innate and adaptive immune features associated with immune-related adverse events (2025 · Journal for ImmunoTherapy of Cancer · 被引 16)
• Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non–small cell lung cancer: a multicentre, single-arm, phase 2 trial (2025 · EClinicalMedicine · 被引 16)
• Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life (2025 · Nature Medicine · 被引 10)
• Patient and Clinician Perspectives on Expanding Telehealth Use for Older Adults Across the Cancer Control Continuum: Mixed Methods Study (2025 · JMIR Cancer · 被引 3)
• Ipilimumab and nivolumab in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated on the phase 3 PDIGREE (Alliance A031704) trial: Results from Step 1 analysis. (2025 · Journal of Clinical Oncology · 被引 3)